Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. Announcements
  3. New "Tips" Document - Document names and descriptions for external use
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

New "Tips" Document - Document names and descriptions for external use

Scheduled Pinned Locked Moved Announcements
1 Posts 1 Posters 597 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • Jennifer CarrollJ Offline
    Jennifer CarrollJ Offline
    Jennifer Carroll
    wrote on last edited by
    #1

    Good Afternoon @Manufacturer and @Agency

    With the increase in digital activities and the transitioning of pieces from print to digital or from digital tools to attached digital downloads, clients increasingly find themselves wanting to add tool names and descriptions at some point in the future therefore triggering the need for submission of an APS update.

    With this in mind, PAAB would like to encourage clients to include this information in their initial submission copy deck template moving forward EVEN if there is no immediate plan to include the tool in a digital platform. Note that PAAB will not be requiring this (although we strongly encourage this as it benefits you). By engaging in this best practice, you enable the PAAB to review the document name (for external use) and description within the review of the original tool. This will help to reduce turnaround times during future submissions where the addition of document names and descriptions are required. This may be of particular importance as these submissions tend to be time sensitive, such as conference booth attachments. In some instances, it will even negate the need for PAAB re-submission (e.g., when simply adding to a list of tools on a third-party platform repository of pharma-generated tools for download in a plain text context, which has been predefined such as eCPS)

    You can view the full “Tips” document here

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Don't have an account? Register

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • Users
    • Groups